Masiba, Veronica S.
HRN: 21-82-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CEFUROXIME 1.5GM (VIAL)
08/17/2022
08/24/2022
IV
1.5 Grams
Q8H
Surgical Prophylaxis; Fracture L Clavicle
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes